LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 39 filers reported holding LUMOS PHARMA INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | – | 117 | -33.5% | 0.00% | – |
| Q2 2023 | $0 | – | 176 | +252.0% | 0.00% | – |
| Q1 2023 | $0 | – | 50 | 0.0% | 0.00% | – |
| Q4 2022 | $0 | -100.0% | 50 | -80.2% | 0.00% | – |
| Q3 2022 | $2,000 | -33.3% | 252 | -39.0% | 0.00% | – |
| Q2 2022 | $3,000 | -25.0% | 413 | -0.5% | 0.00% | – |
| Q1 2022 | $4,000 | +100.0% | 415 | +91.2% | 0.00% | – |
| Q4 2021 | $2,000 | 0.0% | 217 | +1.9% | 0.00% | – |
| Q3 2021 | $2,000 | -33.3% | 213 | -15.1% | 0.00% | – |
| Q2 2021 | $3,000 | 0.0% | 251 | 0.0% | 0.00% | – |
| Q1 2021 | $3,000 | 0.0% | 251 | +248.6% | 0.00% | – |
| Q4 2020 | $3,000 | +200.0% | 72 | +89.5% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 38 | -32.1% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 56 | -71.6% | 0.00% | – |
| Q1 2020 | $1,000 | – | 197 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PVG ASSET MANAGEMENT CORP | 10,175 | $70,512,000 | 0.26% |
| Minerva Advisors LLC | 34,015 | $236,000 | 0.14% |
| Investors Financial Group, LLC | 30,600 | $212,000 | 0.10% |
| Lion Point Capital, LP | 51,205 | $354,000 | 0.10% |
| NEA Management Company, LLC | 376,916 | $2,612,000 | 0.05% |
| Wealth Advisors of Iowa, LLC | 11,699 | $81,000 | 0.04% |
| Paladin Advisory Group, LLC | 4,382 | $30,000 | 0.02% |
| Marquette Asset Management, LLC | 13,315 | $92,000 | 0.02% |
| Blackstone Inc. | 468,145 | $3,244,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 47,643 | $331,000 | 0.01% |